Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine receptor antagonism by the novel antianxiety drug, buspirone.

× No keyword cloud information.

29 in total

1. Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors: Manfred Gerlach; Jürgen Beck; Peter Riederer; Maarten van den Buuse
Journal: J Neural Transm (Vienna) Date: 2011-01-28 Impact factor: 3.575

2. Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.

Authors: Adam S Olsen; Christopher N Sozda; Jeffrey P Cheng; Ann N Hoffman; Anthony E Kline
Journal: J Neurotrauma Date: 2012-04-23 Impact factor: 5.269

3. Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers.

Authors: I M Anderson; P J Cowen
Journal: Psychopharmacology (Berl) Date: 1992 Impact factor: 4.530

4. Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats.

Authors: Vera Bubenikova-Valesova; Jan Svoboda; Jiri Horacek; Tomiki Sumiyoshi
Journal: Psychopharmacology (Berl) Date: 2010-07-31 Impact factor: 4.530

5. Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits.

Authors: Matthew R Skinner; Andrew G Ramage; David Jordan
Journal: Br J Pharmacol Date: 2002-11 Impact factor: 8.739

6. Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.

Authors: R J Rodgers; J K Shepherd
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

Dopamine receptor antagonism by the novel antianxiety drug, buspirone.

1. Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

2. Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.

3. Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers.

4. Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats.

5. Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits.

6. Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.

7. The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity.

8. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.

9. Effect of the 5-HT1A partial agonist buspirone on regional cerebral blood flow in man.

10. Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.